HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences

被引：0
|
作者：
Mikasi, Sello Given [1 ]
Isaacs, Darren [2 ]
Ikomey, George Mondinde [3 ]
Shimba, Henerico [1 ,4 ]
Cloete, Ruben [3 ]
Jacobs, Graeme Brendon [1 ]
机构：
[1] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Pathol, Div Med Virol, ZA-7505 Cape Town, South Africa
[2] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Bioinformat Unit, Cape Town, South Africa
[3] Univ Yaounde I, Fac Med & Biomed Sci, Ctr Study & Control Communicable Dis, Yaounde, Cameroon
[4] Bugando Med Ctr, Mwanza, Tanzania
来源：
AIDS RESEARCH AND HUMAN RETROVIRUSES | 2021年 / 37卷 / 01期
基金：
英国医学研究理事会; 新加坡国家研究基金会;
关键词：
HIV-1; integrase; resistance; Cameroon; diversity; CRF02_AG; DOLUTEGRAVIR; RALTEGRAVIR;
D O I：
10.1089/aid.2020.0022
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
HIV-1 integrase (IN) is a primary target for combination antiretroviral therapy. Only a limited number of studies report on the emergence of resistance-associated mutations (RAMs) in Cameroon. We observed that 1.4% of sequence from treatment-naive patients had IN strand transfer inhibitor (INSTI) RAMs. These mutations confer resistance to raltegravir and elvitegravir. We also observed that 10.1% of the sequences have INSTI accessory RAMs. HIV-1 CRF02_AG was the predominant subtype (44.7%) in this study analyses. The occurrence of INSTI RAMs among the sequences at baseline needs to be monitored carefully.
引用
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [21] An HIV-1 integrase genotype assay for the detection of drug resistance mutations
    Hearps, Anna C.
    Greengrass, Vicki
    Hoy, Jennifer
    Crowe, Suzanne M.
    SEXUAL HEALTH, 2009, 6 (04) : 305 - 309
  • [22] Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor
    Goethals, Olivia
    Van Ginderen, Marcia
    Vos, Ann
    Cummings, Maxwell D.
    Van Der Borght, Koen
    Van Wesenbeeck, Liesbeth
    Feyaerts, Maxim
    Verheyen, Ann
    Smits, Veerle
    Van Loock, Marnix
    Hertogs, Kurt
    Schols, Dominique
    Clayton, Reginald F.
    ANTIVIRAL RESEARCH, 2011, 91 (02) : 167 - 176
  • [23] Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
    Tzou, Philip L.
    Rhee, Soo-Yon
    Descamps, Diane
    Clutter, Dana S.
    Hare, Bradley
    Mor, Orna
    Grude, Maxime
    Parkin, Neil
    Jordan, Michael R.
    Bertagnolio, Silvia
    Schapiro, Jonathan M.
    Harrigan, P. Richard
    Geretti, Anna Maria
    Marcelin, Anne-Genevieve
    Shafer, Robert W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (01) : 170 - 182
  • [24] DOCKING OF RALTEGRAVIR TO HIV-1 INTEGRASE STRUCTURE ENSEMBLE
    Wei, Caiyi
    Liu, Zeyu
    Zhang, Dawei
    Mei, Ye
    JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY, 2010, 9 (06): : 1053 - 1063
  • [25] Structural Comparison of Diverse HIV-1 Subtypes using Molecular Modelling and Docking Analyses of Integrase Inhibitors
    Isaacs, Darren
    Mikasi, Sello Given
    Obasa, Adetayo Emmanuel
    Ikomey, George Mondinde
    Shityakov, Sergey
    Cloete, Ruben
    Jacobs, Graeme Brendon
    VIRUSES-BASEL, 2020, 12 (09):
  • [26] Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients
    Sayan, M.
    Gunduz, A.
    Ersoz, G.
    Inan, A.
    Deveci, A.
    Ozgur, G.
    Sargin, F.
    Karagoz, G.
    Inci, A.
    Inan, D.
    Ulcay, A.
    Karaoglan, I.
    Kaya, S.
    Kutlu, S. S.
    Suer, K.
    Cagatay, A.
    Akalin, H.
    HIV CLINICAL TRIALS, 2016, 17 (03): : 109 - 113
  • [27] An Evolutionary Model-Based Approach To Quantify the Genetic Barrier to Drug Resistance in Fast-Evolving Viruses and Its Application to HIV-1 Subtypes and Integrase Inhibitors
    Theys, Kristof
    Libin, Pieter J. K.
    Van Laethem, Kristel
    Abecasis, Ana B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [28] Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir
    Rhee, Soo-Yon
    Parkin, Neil
    Harrigan, P. Richard
    Holmes, Susan
    Shafer, Robert W.
    ANTIVIRAL RESEARCH, 2022, 208
  • [29] Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout
    Osman, Nathan
    Mesplede, Thibault
    Oliveira, Maureen
    Hassounah, Said
    Wainberg, Mark A.
    Brenner, Bluma G.
    AIDS, 2018, 32 (13) : 1773 - 1780
  • [30] HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants
    Smith, Steven J.
    Zhao, Xue Zhi
    Passos, Dario Oliveira
    Lyumkis, Dmitry
    Burke, Terrence R., Jr.
    Hughes, Stephen H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
12345